🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic Surveillance After ESD

RecruitingNAAges 18 Years - 80 YearsAllXijing Hospital of Digestive Diseases
NCT06092281 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Endoscopic submucosal dissection (ESD) is now considered the standard treatment for early gastrointestinal neoplasms. However, there is still a possibility of developing local recurrence or metachronous neoplasia after ESD. Regular endoscopic surveillance after ESD can identify and remove local recurrences and metachronous lesions early, improving patient prognosis. However, the patient compliance with post-ESD endoscopic surveillance is currently unclear, and many patients fail to adhere to the scheduled follow-up. A prospective, randomized controlled, superiority trial was designed to evaluate whether completing a questionnaire and receiving feedback on compliance-related education can improve patient compliance with post-ESD endoscopic surveillance, in comparison to those who did not complete the compliance-related education questionnaire. Additionally, the investigators intend to inv

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients (≥18 years) after ESD for mucosal lesions. Exclusion Criteria: * Patients after ESD for submucosal tumors, e.g. stromal tumors, neuroendocrine tumors; * Additional radical surgery after ESD procedure; * Past history of ESD procedure or local recurrence; * Severe comorbidities with a life expectancy of \<6 months as judged by the investigator; * Unable to cooperate with information collection due to mental disorders, severe neurosis, or dysgnosia; * Unable to understand or unwilling to sign a written informed consent.
💊

What it tests

  • Questionnaire
  • Questionnaire without compliance-related education
📍

Where

1 site
Xijing Hospital of Digestive Disease
Xi'an, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy